Emergent BioSolutions Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Emergent BioSolutions Inc. on April 29, 2009, regarding events occurring on that date. The report discloses the entry into a material definitive agreement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed relates to the new consulting agreement:
- Consulting Fee: $15,000 per month.
- Expenses: Reimbursement of reasonable out-of-pocket expenses.
Material Changes
The Company entered into a new consulting services agreement with The Hauer Group, effective April 1, 2009. This agreement replaces a prior contract for similar services that expired on the same date. The Hauer Group provides strategic consulting and domestic and international marketing advice.
Related Party Transaction and Governance
This is a related party transaction. Jerome Hauer, a member of the Company's Board of Directors, serves as the chief executive officer of The Hauer Group. Mr. Hauer and his wife are the sole owners of The Hauer Group.
Agreement Terms
- Term: Expires on April 1, 2010, unless extended by mutual agreement.
- Services: Strategic consulting and marketing advice.
Investor Verification Checklist
- Verify the total annual cost of the agreement ($180,000) relative to the Company's current operating budget.
- Review the Company's related party transaction policies and Board approval documentation for this agreement.
- Assess the specific deliverables and performance metrics defined in the consulting agreement to ensure value for the $15,000 monthly fee.
- Confirm if there are any other undisclosed agreements with The Hauer Group or Jerome Hauer.